重症患者-话题@MedSci

#重症患者#

162篇内容 | 2115人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1284117, encodeId=72ad128411e2b, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Annals of Neurology：新冠重症患者中神经元损伤常见且明显, objectType=article, longId=206180, objectId=8ae5206180ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae5206180ac, replyNumber=0, likeNumber=61, createdTime=2021-01-25, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae5206180ac, moduleTitle=Annals of Neurology：新冠重症患者中神经元损伤常见且明显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae5206180ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284116, encodeId=f69b12841167d, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Lancet：疲劳、乏力、睡眠困难、焦虑及抑郁是新冠肺炎患者康复后常见的异常体征，重症患者肺弥散功能受损, objectType=article, longId=205534, objectId=37df2055344e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37df2055344e, replyNumber=0, likeNumber=132, createdTime=2021-01-11, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37df2055344e, moduleTitle=Lancet：疲劳、乏力、睡眠困难、焦虑及抑郁是新冠肺炎患者康复后常见的异常体征，重症患者肺弥散功能受损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37df2055344e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284115, encodeId=ed861284115d7, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Tocilizumab和sarilumab降低了COVID-19重症患者的死亡风险, objectType=article, longId=205521, objectId=fbd9205521cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd9205521cd, replyNumber=0, likeNumber=66, createdTime=2021-01-10, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd9205521cd, moduleTitle=Tocilizumab和sarilumab降低了COVID-19重症患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbd9205521cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284114, encodeId=973b128411400, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Crit Care：伴有急性肾脏损伤的重症患者启动肾脏替代治疗的时机, objectType=article, longId=205510, objectId=8e9b2055103f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e9b2055103f, replyNumber=0, likeNumber=92, createdTime=2021-01-10, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e9b2055103f, moduleTitle=Crit Care：伴有急性肾脏损伤的重症患者启动肾脏替代治疗的时机, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e9b2055103f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284113, encodeId=b3741284113ba, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=地下停车场改新冠重症患者病房！美国一急救医生自拍照引热议, objectType=article, longId=204176, objectId=e0092041e6f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0092041e6f9, replyNumber=0, likeNumber=83, createdTime=2020-12-07, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0092041e6f9, moduleTitle=地下停车场改新冠重症患者病房！美国一急救医生自拍照引热议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0092041e6f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284112, encodeId=30f8128411293, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Cell Prolif ：重大进展，同济大学左为团队研究揭示新冠重症患者肺部干细胞可参与肺损伤修复, objectType=article, longId=202658, objectId=59e320265843, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59e320265843, replyNumber=0, likeNumber=60, createdTime=2020-10-31, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59e320265843, moduleTitle=Cell Prolif ：重大进展，同济大学左为团队研究揭示新冠重症患者肺部干细胞可参与肺损伤修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59e320265843)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284111, encodeId=826a1284111a5, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=AJKD：连续肾脏替代治疗的重症患者肌酐-胱抑素C比值与死亡率的关系, objectType=article, longId=202505, objectId=f86b202505ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f86b202505ec, replyNumber=0, likeNumber=76, createdTime=2020-10-27, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f86b202505ec, moduleTitle=AJKD：连续肾脏替代治疗的重症患者肌酐-胱抑素C比值与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f86b202505ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284110, encodeId=f27112841105c, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=EClinicalMedicine：托珠单抗治疗会增加COVID-19重症患者死亡风险, objectType=article, longId=202183, objectId=3a6d2021831d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a6d2021831d, replyNumber=0, likeNumber=85, createdTime=2020-10-17, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a6d2021831d, moduleTitle=EClinicalMedicine：托珠单抗治疗会增加COVID-19重症患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a6d2021831d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284109, encodeId=f0b11284109c8, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Am J Pathol：对于COVID-19重症患者，输注康复期血浆是一种安全的治疗方案, objectType=article, longId=199002, objectId=102119900214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=102119900214, replyNumber=0, likeNumber=60, createdTime=2020-08-09, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=102119900214, moduleTitle=Am J Pathol：对于COVID-19重症患者，输注康复期血浆是一种安全的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=102119900214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284108, encodeId=49c51284108e0, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=世卫组织：研究显示地塞米松可挽救新冠肺炎重症患者生命, objectType=article, longId=196023, objectId=13881960234b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13881960234b, replyNumber=0, likeNumber=95, createdTime=2020-06-19, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13881960234b, moduleTitle=世卫组织：研究显示地塞米松可挽救新冠肺炎重症患者生命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13881960234b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284107, encodeId=e009128410e35, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=以色列：开发出新冠肺炎重症患者远程监视系统, objectType=article, longId=194206, objectId=20051942064c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20051942064c, replyNumber=0, likeNumber=56, createdTime=2020-05-17, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20051942064c, moduleTitle=以色列：开发出新冠肺炎重症患者远程监视系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20051942064c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284106, encodeId=d65d128410655, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=瑞德西韦获批成日本国内**新冠治疗药物，优先用于重症患者, objectType=article, longId=193829, objectId=333719382925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=333719382925, replyNumber=0, likeNumber=68, createdTime=2020-05-10, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=333719382925, moduleTitle=瑞德西韦获批成日本国内**新冠治疗药物，优先用于重症患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=333719382925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284105, encodeId=e1091284105aa, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=美国研究报告：血液稀释剂可能改善新冠重症患者症状, objectType=article, longId=193677, objectId=1d1f1936e70d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d1f1936e70d, replyNumber=0, likeNumber=77, createdTime=2020-05-09, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d1f1936e70d, moduleTitle=美国研究报告：血液稀释剂可能改善新冠重症患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d1f1936e70d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284104, encodeId=c992128410429, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=李太生教授团队：高剂量静脉注射免疫球蛋白——COVID-19重症患者安全有效的普适疗法, objectType=article, longId=193475, objectId=dec21934e59a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec21934e59a, replyNumber=0, likeNumber=67, createdTime=2020-05-06, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec21934e59a, moduleTitle=李太生教授团队：高剂量静脉注射免疫球蛋白——COVID-19重症患者安全有效的普适疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec21934e59a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284103, encodeId=1efe12841037b, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=Crit Care：重症患者少尿的临床意义, objectType=article, longId=192969, objectId=1bec192969d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bec192969d2, replyNumber=0, likeNumber=86, createdTime=2020-04-27, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bec192969d2, moduleTitle=Crit Care：重症患者少尿的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bec192969d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284102, encodeId=5e01128410241, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=NEJM：瑞德西韦治疗COVID-19重症患者，68%病情改善，60%报告不良事件, objectType=article, longId=192768, objectId=73b2192e68ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b2192e68ac, replyNumber=0, likeNumber=83, createdTime=2020-04-24, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b2192e68ac, moduleTitle=NEJM：瑞德西韦治疗COVID-19重症患者，68%病情改善，60%报告不良事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73b2192e68ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284101, encodeId=0964128410169, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=新冠肺炎重症患者皮肤为啥会变黑？, objectType=article, longId=192698, objectId=af8b192698b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af8b192698b0, replyNumber=0, likeNumber=0, createdTime=2020-04-23, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af8b192698b0, moduleTitle=新冠肺炎重症患者皮肤为啥会变黑？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af8b192698b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284100, encodeId=25241284100e4, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=medRxiv.: 华西领衔的“川军”战队分享COVID-19重症患者的救治经验, objectType=article, longId=192456, objectId=386a1924563c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=386a1924563c, replyNumber=0, likeNumber=70, createdTime=2020-04-19, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=386a1924563c, moduleTitle=medRxiv.: 华西领衔的“川军”战队分享COVID-19重症患者的救治经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=386a1924563c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284099, encodeId=eb88128409980, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=韩国首次运用血清疗法成功治愈两名新冠重症患者，一名已出院, objectType=article, longId=191899, objectId=27bd191899e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27bd191899e6, replyNumber=0, likeNumber=56, createdTime=2020-04-11, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27bd191899e6, moduleTitle=韩国首次运用血清疗法成功治愈两名新冠重症患者，一名已出院, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27bd191899e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1284098, encodeId=7a1d128409876, content=<a href='/topic/show?id=cdb79594643' target=_blank style='color:#2F92EE;'>#重症患者#</a>, objectTitle=“血清疗法”可用于COVID-19重症患者的治疗, objectType=article, longId=191758, objectId=bd54191e588a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd54191e588a, replyNumber=0, likeNumber=77, createdTime=2020-04-10, rootId=0, userName=longqijun248, userId=6c3a189, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd54191e588a, moduleTitle=“血清疗法”可用于COVID-19重症患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd54191e588a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重症患者

2020-05-29

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Annals of Neurology：新冠重症患者中神经元损伤常见且明显

2021-01-25

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Lancet：疲劳、乏力、睡眠困难、焦虑及抑郁是新冠肺炎患者康复后常见的异常体征，重症患者肺弥散功能受损

2021-01-11

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Tocilizumab和sarilumab降低了COVID-19重症患者的死亡风险

2021-01-10

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Crit Care：伴有急性肾脏损伤的重症患者启动肾脏替代治疗的时机

2021-01-10

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

地下停车场改新冠重症患者病房！美国一急救医生自拍照引热议

2020-12-07

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Cell Prolif ：重大进展，同济大学左为团队研究揭示新冠重症患者肺部干细胞可参与肺损伤修复

2020-10-31

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

AJKD：连续肾脏替代治疗的重症患者肌酐-胱抑素C比值与死亡率的关系

2020-10-27

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

EClinicalMedicine：托珠单抗治疗会增加COVID-19重症患者死亡风险

2020-10-17

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Am J Pathol：对于COVID-19重症患者，输注康复期血浆是一种安全的治疗方案

2020-08-09

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

世卫组织：研究显示地塞米松可挽救新冠肺炎重症患者生命

2020-06-19

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

以色列：开发出新冠肺炎重症患者远程监视系统

2020-05-17

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

瑞德西韦获批成日本国内**新冠治疗药物，优先用于重症患者

2020-05-10

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

美国研究报告：血液稀释剂可能改善新冠重症患者症状

2020-05-09

智慧医人 (审核中...)

前往app查看评论内容

#重症患者#

李太生教授团队：高剂量静脉注射免疫球蛋白——COVID-19重症患者安全有效的普适疗法

2020-05-06

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

Crit Care：重症患者少尿的临床意义

2020-04-27

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

NEJM：瑞德西韦治疗COVID-19重症患者，68%病情改善，60%报告不良事件

2020-04-24

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

新冠肺炎重症患者皮肤为啥会变黑？

2020-04-23

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

medRxiv.: 华西领衔的“川军”战队分享COVID-19重症患者的救治经验

2020-04-19

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

韩国首次运用血清疗法成功治愈两名新冠重症患者，一名已出院

2020-04-11

longqijun248 (审核中...)

前往app查看评论内容

#重症患者#

“血清疗法”可用于COVID-19重症患者的治疗

2020-04-10

科室
- - 订阅+
  - 更多科室
工具
服务